Liquidia Corporation Common Stock vs Qnity Electronics Inc. Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.46 (market cap $2.40B), while Qnity Electronics Inc. Common Stock trades at $119 (market cap $25.71B). The key difference: Qnity Electronics Inc. Common Stock is far larger — about 10.7× Liquidia Corporation Common Stock's market cap, and Qnity Electronics Inc. Common Stock pays a 0.26% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Qnity Electronics Inc. Common Stock for 6 Days on average.
| LQDA | Q | |
|---|---|---|
Market Cap | $2.40B | $25.71B |
Volume | 2,857,547 | 1,883,674 |
Sector | Health | Technology |
52-Week High | $91.03 | $175.64 |
52-Week Low | $22.02 | $73.54 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $2.30B | $28.77B |
Dividend Yield | — | 0.26% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Qnity Electronics (Q) trades at $122.95, down 0.21% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $4.75B in 2025, though net income margin is expected to dip in 2026. Recent news highlights product launches in AI data center cooling and advanced packaging, alongside inclusion in the PHLX Semiconductor Index.
The stock presents a mixed outlook: strong analyst consensus (100% buy ratings) and a $180 price target suggest significant upside, but technical weakness and a high P/E ratio of 43.9 pose risks. Key opportunities include AI-driven demand and advanced packaging growth, while risks involve execution in a competitive semiconductor market and potential margin pressure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Qnity Electronics provides materials and solutions for semiconductor manufacturing and electronic systems. Its portfolio supports chip fabrication, advanced packaging, interconnects, and thermal management.
Read more on Q →